Bio
Credentials
-
Series 7, 63, 86, 87
FINRA
Experience
-
Candriam
-
London, England, United Kingdom
-
Senior Biotech Analyst
-
Jul 2022 - Present
-
London, England, United Kingdom
-
-
-
Weill Cornell Medicine
-
Greater New York City Area
-
Instructor
-
Dec 2016 - Present
-
Greater New York City Area
Conduct independent and collaborative research in the area of tumor stem cell biology and extracellular vesicles/exosomes research
-
-
-
J. Goldman & Co., L.P.
-
New York, New York, United States
-
Oncology Investment Analyst
-
Mar 2021 - Jun 2022
-
New York, New York, United States
-
-
-
Alera Partners LP
-
Stamford, Connecticut, United States
-
Oncology Investment Analyst
-
May 2020 - Mar 2021
-
Stamford, Connecticut, United States
Alera Partners is a global healthcare focused investment management firm specializing in the biotechnology, pharmaceuticals and medical technology sectors. Alera’s flagship equity long/short fund employs an absolute return, low net strategy and targets low teen net uncorrelated returns with low v...
-
-
-
H.C. Wainwright & Co., LLC
-
New York City Metropolitan Area
-
Biotech Equity Research Associate
-
Jan 2018 - May 2020
-
New York City Metropolitan Area
-
-
-
Memorial Sloan-Kettering Cancer Center
-
New York City Metropolitan Area
-
Postdoctoral Research Scholar Breast Cancer
-
Jan 2009 - May 2020
-
New York City Metropolitan Area
Therapy Resistant Breast Cancer and Cancer Stem Cell biology
-
-
-
Alma Mater Studiorum University of Bologna
-
Bologna Area, Italy
-
Fellow in Experimental Pathology
-
Dec 2004 - Jan 2006
-
Bologna Area, Italy
Cancer Stem Cell biology
-
-
Education
-
1999 - 2009Università di Bologna
Suggested Services
This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection
Industry Focus. “Financial Services”
Need a custom project? We'll create a solution designed specifically for your project.
References
Social Profiles
Community